Biocon Ltd. Share Price Updates Biocon Ltd. share price down by down by -1.85% -1.71% from its previous close of Rs 268.20 268.60 . Biocon Ltd. stock last traded price is 263.25 264.00 Symbol P/E: 69.22 Sectoral Index P/E: 31.53 Face value (Rs.) The upper and lower price bands, for scrips on which derivative products are available or scrips included in indices on which derivative products are available, are on the basis of dynamic price band of 10%. The last bonus that Biocon had announced was in 2019 in the ratio of 1:1. The share has been quoting ex-bonus from June 12, 2019. Bonus History (Biocon) History. Biocon was founded in 1978 with ₹ 10,000 (US$140) as the initial capital. Biocon's first product to go to market was papain, an enzyme found in papaya which is used to prevent beer from turning hazy.
Stock analysis of Biocon (BIOCON) with Birds eye view On its Returns, highs/ lows, Technicals, Fundamentals & future Share Price History of Biocon Ltd.
Stock analysis of Biocon (BIOCON) with Birds eye view On its Returns, highs/ lows, Technicals, Fundamentals & future Share Price History of Biocon Ltd. Biocon Limited. Minimize Indicators. NSE »BIOCON AND BSE »532523. Lower Indicators Unilever plc. acquired Biocon Biochemicals Ltd. in Ireland and merged it with its subsidiary, Quest International. Biocon was the first Indian biotech company to Invest in BIOCON; Get Live NSE/BSE/F&O Quote of with 52 week high & low, average daily movement & major Support & Resistance. Biocon Ltd Stock Chart and Share Price Forecast, Short-Term "BIOCON" Stock Prediction for Next Latest Biocon Share Price in NSE and BSE. The market cap of Biocon Limited as of March 2018 is more than Rs.35,000 crore. History of the Company.
(20-AUG-19); Lower Price Band227.20; Upper Price Band277.60; Adjusted Price --. Order Book; Intra-day. Chart; Stock V/s Index Chart; Quarterly Charts
Symbol P/E: 69.22 Sectoral Index P/E: 31.53 Face value (Rs.) The upper and lower price bands, for scrips on which derivative products are available or scrips included in indices on which derivative products are available, are on the basis of dynamic price band of 10%. The last bonus that Biocon had announced was in 2019 in the ratio of 1:1. The share has been quoting ex-bonus from June 12, 2019. Bonus History (Biocon) History. Biocon was founded in 1978 with ₹ 10,000 (US$140) as the initial capital. Biocon's first product to go to market was papain, an enzyme found in papaya which is used to prevent beer from turning hazy. Biocon Limited Share Price Today, Live NSE Stock Price: Get the latest Biocon Limited news, company updates, quotes, offers, annual financial reports, graph, volumes, 52 week high low, buy sell tips, balance sheet, historical charts, market performance, capitalisation, dividends, volume, profit and loss account, research, results and more details at NSE India.
Biocon Ltd. Share Price Updates Biocon Ltd. share price down by down by -1.85% -1.71% from its previous close of Rs 268.20 268.60 . Biocon Ltd. stock last traded price is 263.25 264.00
The last bonus that Biocon had announced was in 2019 in the ratio of 1:1. The share has been quoting ex-bonus from June 12, 2019. Bonus History (Biocon) History. Biocon was founded in 1978 with ₹ 10,000 (US$140) as the initial capital. Biocon's first product to go to market was papain, an enzyme found in papaya which is used to prevent beer from turning hazy.
Biocon Limited. Minimize Indicators. NSE »BIOCON AND BSE »532523. Lower Indicators
(20-AUG-19); Lower Price Band227.20; Upper Price Band277.60; Adjusted Price --. Order Book; Intra-day. Chart; Stock V/s Index Chart; Quarterly Charts Biocon Ltd Live BSE Share Price today, Biocon latest news, 532523 announcements. Biocon financial results, Biocon shareholding, Biocon annual reports, Biocon Financial Trend is the latest financial score of the company using over 200 Biocon Limited (BSE: 532523) is an Indian biopharmaceutical company based in Bangalore, 1 History; 2 Corporate Governance; 3 Subsidiaries, Acquisitions and Strategic Global Alliances. 3.1 Syngene Mylan and Biocon will share development, capital and other costs to bring products to market. Mylan will have